
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Our stance on Trump’s drug pricing executive order
The National Community Pharmacists Association released their stance on Trump’s “Most Favorable Pricing” Executive Order, signed on Monday, May 12th.

NCPA Joins Class Action Suit Against GoodRx; CVS Caremark Corp.; Express Scripts, Inc.; MedImpact Healthcare Systems, Inc.; and Navitus Health Solutions, LLC
Says the discount card company is colluding with the named PBMs to fix reimbursements
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.